25-Jan-15The Chinese pharmaceutical sector saw lower growth in 2014 due to a host of challenges including slowing overall economic growth, regulatory shakeups, cost containment measures and price cuts, as well as healthcare reform turbulence. However, the market is still estimated to have grown 13% in 2014, to reach USD200 billion. [image: My Jungle Blog]

For more about China's healthcare sector, request our free 20-page whitepaper: China Healthcare Market Opportunities

09-Jan-15 The China Food and Drug Administration (CFDA) plans to allow online sales of prescription drugs soon. If approved, the policy could seed a market worth more than USD160 billion as sales shift from hospitals to online platforms such as Alibaba and JD.com. [image: Reuters/Stringer]

14-Jan-15 Overall, the Chinese government created lots of space for the private sector in 2014, meaning demand remained strong and companies benefited. This trend is likely to continue in 2015, especially if initiatives such as online drug sales, foreign participation in health services, and more funding for doctors’ pay, CFDA and telemedicine, are continued. [image: Forbes]

09-Jan-15 To enable more private operators to relieve the pressure on China’s over-burdened healthcare sector, the government is encouraging physicians to practice at more than one institution, by reforming the doctor registration system, initially on a trial basis. Currently, most physicians work in public hospitals and need permission from the hospital to practice elsewhere. [image: YourHealth]

08-Jan-15 The Food & Drug Administration in Taiwan has reiterated its determination to facilitate easy access to drugs to further promote responsible self-medication, which it says can save people time waiting in hospitals and clinics, as well as considerable National Health Insurance spending. [image: GBI Research]